First human test: how kidneys handle new drug
NCT ID NCT07165015
Summary
This is an early safety study to understand how a new drug, LY3537031, moves through and leaves the body. It will compare people with healthy kidney function to those with severe kidney impairment or kidney failure. The main goal is to measure drug levels in the blood and check for safety in these different groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Indiana University School of Medicine
NOT_YET_RECRUITINGIndianapolis, Indiana, 46202-5188, United States
Contact Phone: •••-•••-••••
Contact
-
New Zealand Clinical Research Christchurch
RECRUITINGChristchurch, New Zealand
Contact Phone: •••-•••-••••
Contact
-
Omega Research Orlando LLC
RECRUITINGOrlando, Florida, 32808, United States
Contact Phone: •••-•••-••••
Contact
-
Orlando Clinical Research Center
ACTIVE_NOT_RECRUITINGOrlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.